durvalumab,sorafenib,tislelizumab,tremelimumab
pfizer,novartis,beigene,astrazeneca
['rationale-301', 'tremelimumab', 'gi ', 'durva', 'hcc', 'sorafenib', 'himalaya', 'tislelizumab']
 world congress on #gastrointestinal #cancer has officially started check out some great abstracts including these including phase 3 trials for treatments for unresectable #hcc, #himilaya study update and proton beam radiotherapy as a curative for hcc 
COR2ED bringing you Independent Medical Education developed 
by HCC CONNECT, international experts in Liver oncology